Johnson & Johnson
Last updated: . For recent data, use our API.
Overview
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.
Learn more at https://www.jnj.com.
Community Guidelines: http://www.jnj.com/social-media-community-guidelines
Private funding before listing
2 rounds. Latest: Funding, 1 Mar 2003.
| Date | Type | Amount |
|---|---|---|
| 1 Mar 2003 | Funding | $3M |
Office locations
Similar companies
- PfizerPharmaceutical Manufacturing · New York
- UnileverManufacturing · Blackfriars, London
- Procter & GambleManufacturing · Cincinnati, Ohio
- BayerChemical Manufacturing · Leverkusen, North Rhine-Westphalia
- NestléFood and Beverage Services
- NovartisPharmaceutical Manufacturing · Basel, Baselstadt
- RocheBiotechnology Research
- SanofiPharmaceutical Manufacturing · Paris, France
- AbbottHospitals and Health Care · Abbott Park, Illinois
- L'OréalPersonal Care Product Manufacturing
Latest videos from Johnson & Johnson on YouTube
The Red Couch on the Road | Creating better outcomes for lung cancer patients | Episode 7
The Red Couch on the Road | Strengthening mental health and well-being of health workers | Episode 6
The Red Couch on the Road | Accessing Healthcare During Natural Disasters with Americares | Ep. 5
The Red Couch on the Road | Nurse Innovation Fellowship | Episode 4
Recent posts from the Johnson & Johnson blog
- Meet the medical engineer behind the innovative heart pump that revolutionized cardiac health
Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 26 years since it entered the market, this groundbreaking device has helped more than 450,000 patients recover from heart injuries.
- Johnson & Johnson’s ICOTYDE® (icotrokinra) named to Time’s Best Inventions of 2026 list
The first-of-its-kind targeted oral peptide therapy for moderate to severe plaque psoriasis has been chosen for the annual list, which recognizes innovations for their originality, ambition and impact.